Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

42.13
+0.50991.23%
Post-market: 42.160.0324+0.08%19:30 EDT
Volume:25.23K
Turnover:1.06M
Market Cap:1.07B
PE:- -
High:42.27
Open:42.27
Low:41.71
Close:41.62
52wk High:42.87
52wk Low:27.30
Shares:25.35M
Float Shares:25.35M
Volume Ratio:0.17
T/O Rate:0.10%
Dividend:0.43
Dividend Rate:1.01%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

Top Bristol-Myers Squibb Executive Makes Notable Move With Recent Stock Sale

TIPRANKS
·
Aug 27

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Bristol Myers Squibb SVP, Controller Phil M. Holzer Sells 500 Shares for $33,750

Reuters
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Eli Lilly Expands Alzheimer’s Pipeline With New Amyloid Phase 1 Trial

TIPRANKS
·
Aug 27

Eli Lilly Stock (LLY) in Focus as Alzheimer’s Blood Test Gets FDA Approval

TIPRANKS
·
Aug 26

Nike, Merck Share Losses Contribute to Dow's 150-Point Drop

Dow Jones
·
Aug 26

Bloomsbury Ties Executive Share Awards to Long-Term Performance Targets

TIPRANKS
·
Aug 26

Eli Lilly and Co Stock (LLY) Opened Down by 3.57% on Aug 26: Facts Behind the Movement

TradingKey
·
Aug 26

Eli Lilly Study Shows Lower Healthcare Costs With Zepbound in Older Adults

MT Newswires Live
·
Aug 26

Gubra Earns USD 50 Million Milestone as AbbVie Starts Phase 2 Trial of Obesity Drug ABBV-295

Reuters
·
Aug 26

Zepbound Linked to Lower Healthcare Costs in Adults over Age 55 with Obesity According to a Real-World Study

THOMSON REUTERS
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)

TIPRANKS
·
Aug 26